# Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

Source: https://onco.cc/trials/nct06409429/  
OnCo record `nct06409429` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial of nimotuzumab in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting.

## Summary

Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer is a phase 2/3, randomised interventional study registered as NCT06409429 by Tianjin Medical University Cancer Institute and Hospital, with a registry enrolment figure of 146 participants, started 2024-05-01 and due to reach its primary completion in 2027-05-30. Interventions recorded: Nimotuzumab; GX; Placebo. Conditions listed: Pancreatic Cancer. Primary outcome: relapse-free survival (RFS). Pancreatic eligibility wording from the registry: "Histologically or cytologically confirmed resected pancreatic ductal adenocarcinoma (PDAC), resectable evaluation is based on criteria of NCCN guidelines, no evidence of distant metastasis as demonstrated by imaging;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06409429
- Phase: 2/3
- Setting: A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Nimotuzumab Combined With GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
- Sponsor: Tianjin Medical University Cancer Institute and Hospital
- Enrolled: 146

## Sources

- ClinicalTrials.gov NCT06409429: https://clinicaltrials.gov/study/NCT06409429

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/), [Resectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/resectable-pdac/)
- drugs: [Nimotuzumab](https://onco.cc/drugs/nimotuzumab/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06409429.json